Pages that link to "Q34452976"
Jump to navigation
Jump to search
The following pages link to Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial (Q34452976):
Displaying 28 items.
- Hypoglycemic agents and potential anti-inflammatory activity (Q26750414) (← links)
- Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes (Q33791968) (← links)
- Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST. (Q34090327) (← links)
- Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis (Q34142893) (← links)
- Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study (Q34762025) (← links)
- Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics (Q35189544) (← links)
- Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial (Q35264479) (← links)
- PAI-1 and diabetes: a journey from the bench to the bedside (Q36249561) (← links)
- Effect of insulin sensitizer therapy on atherothrombotic and inflammatory profiles associated with insulin resistance (Q36397303) (← links)
- Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report (Q36686775) (← links)
- Clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients (Q36804738) (← links)
- Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core. (Q36872650) (← links)
- Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases (Q37017506) (← links)
- Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. (Q37193699) (← links)
- Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial (Q37193704) (← links)
- Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study. (Q37427000) (← links)
- Prognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study (Q37556069) (← links)
- Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial (Q37715525) (← links)
- Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death (Q38747883) (← links)
- Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study (Q40840703) (← links)
- An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes). (Q41627043) (← links)
- Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial (Q42373687) (← links)
- Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Q57688763) (← links)
- Sudden Cardiac Death (SCD) – risk stratification and prediction with molecular biomarkers (Q63987361) (← links)
- Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease (Q64239248) (← links)
- The impact of oral anti-diabetic medications on heart failure: lessons learned from preclinical studies (Q88013533) (← links)
- BARI 2D: A Reanalysis Focusing on Cardiovascular Events (Q90571302) (← links)
- Aerobic exercise training may improve nerve function in type 2 diabetes and pre-diabetes: A systematic review (Q93273490) (← links)